000 | 01305 a2200277 4500 | ||
---|---|---|---|
005 | 20250514020400.0 | ||
264 | 0 | _c20020122 | |
008 | 200201s 0 0 eng d | ||
022 | _a1198-743X | ||
024 | 7 |
_a10.1046/j.1198-743x.2001.00295.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJacobs, M R | |
245 | 0 | 0 |
_aOptimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. _h[electronic resource] |
260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cNov 2001 |
||
300 |
_a589-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacokinetics |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 |
_aHaemophilus influenzae _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 7 _gno. 11 _gp. 589-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1198-743x.2001.00295.x _zAvailable from publisher's website |
999 |
_c11650543 _d11650543 |